Evidence map›Paper›PMID 38711891›Full record

ArticleAME case reports2024

Case report: familial hypocalciuric hypercalcemia.

Abdullah Al-Ramdhan, Abdullah Al-Ashwal, Hanan Albagshi, Ahmed Alhamrani, Eman Fahmy, Hassan Alhamrani, Ibrahem Ben Solan

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullah Al-RamdhanDepartment of Family Medicine, Al Ahsa Family Medicine Academy, Hofuf, Saudi Arabia.
Abdullah Al-AshwalDiabetes and Endocrinology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Hanan AlbagshiDepartment of Internal Medicine, King Fahad General Hospital, Al Ahasa, Saudi Arabia.
Ahmed AlhamraniDepartment of Pediatrics, Maternity and Child Hospital, Alahasa, Saudi Arabia.
Eman FahmyDiabetes and Endocrinology, Faculty of Medicine, Helwan University, Helwan, Egypt.
Hassan AlhamraniDiabetes and Endocrinology, Almana Hospital, Dammam, Saudi Arabia.
Ibrahem Ben SolanLaboratory Department, King Fahad Hospital, Al Ahsa, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Familial hypocalciuric hypercalcemia (FHH) is a hypercalcemic syndrome that is usually characterized by uncomplicated hypercalcemia and normal longevity. The inheritance pattern is autosomal dominant with high penetrance, and it affects both men and women equally. FHH is caused by mutations that disturb the normal functioning of the calcium-sensing receptor ( Case Description: We report a case of a healthy 24-year-old female with longstanding hypercalcemia and a family history indicating asymptomatic hypercalcemia. The patient was also asymptomatic and had no significant past medical or surgical history. Laboratory investigations and the genetic study revealed findings suggestive of FHH subtype 1. Conclusions: The phenotype of FHH is normal, and symptoms of hypercalcemia are usually not present. Patients with FHH and hypoparathyroidism have lower calcium clearance than controls with hypoparathyroidism. This shows that relative hypocalciuria in FHH is not caused by hyperparathyroidism. Since calcium does not appropriately suppress or affect the parathyroid glands in FHH, this means that FHH is a disorder of abnormal transport of extracellular calcium and/or response to it in at least two organs, the parathyroid gland and the kidney. It is quite similar to primary hyperparathyroidism (pHPT) biochemically hence it is important to differentiate this condition from pHPT and hypercalcemia caused by other diseases to avoid any unnecessary surgical or medical intervention.

Indexed as

asymptomaticcalciumcase reportFamilial hypocalciuric hypercalcemia (FHH)hypercalcemic

Identifiers

PMID38711891
PMCPMC11070985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.